Cover Image
市場調查報告書

週邊動脈疾病 (PAD):主要20個市場預測 2016-2026年

Peripheral Arterial Disease Forecast in 20 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 353260
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
週邊動脈疾病 (PAD):主要20個市場預測 2016-2026年 Peripheral Arterial Disease Forecast in 20 Major Markets 2016-2026
出版日期: 2016年03月01日 內容資訊: 英文 80 Pages
簡介

週邊動脈疾病 (PAD) 是末梢動脈的閉塞,視為個人的全身性動脈粥狀硬化負擔的檢測標準。還有一般PAD,定義為腳關節上臂血壓比 (APBI) 0.9以下。PAD,又稱為末梢動脈閉塞性疾病,閉塞性動脈硬化症,下肢閉塞性疾病及末稍血管疾病。

本報告提供主要20個市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本、印度、墨西哥、土耳其、希臘、荷蘭、沙烏地阿拉伯、韓國、中國、阿根廷、加拿大、澳洲及瑞典) 的週邊動脈疾病 (PAD的)目前患者數 (性別、各年齡世代) 調查分析,目前盛行率,加上疾病概要,危險因素,疾病診斷預後,主要的症狀和併發症等系統性資訊

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化做患者數的手法

週邊動脈疾病 (PAD) 的盛行率top line

週邊動脈疾病 (PAD) 的特徵

  • PAD的重病度及症狀
  • 症候性PAD患者的症狀簡介
  • PAD患者的膽固醇值
  • PAD相關的疾病

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文獻

附錄

目錄
Product Code: PALD0010216

image1

Peripheral Arterial disease (PAD) is an occlusion of the peripheral arteries and is widely viewed as a measure of an individual's global systemic atherosclerotic burden. Typically, it is defined as an ankle-brachial pressure index (APBI) ratio of <0.9. PAD can also be known as peripheral arterial occlusive disease, arteriosclerosis obliterans, lower extremity occlusive disease and peripheral vascular disease.

This report provides the current prevalent population for PAD across 20 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Greece, Netherlands, Saudi Arabia, Republic of Korea, China, Argentina, Canada, Australia and Sweden) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of PAD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for PAD include:

  • Hypertension
  • Family history of PAD
  • Dyslipidaemia
  • Obesity
  • Diabetes
  • Lower limb ischemia
  • Myocardial infarction
  • Coronary artery disease (CAD)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global PAD's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of PAD and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on PAD's prevalent population.
  • Identify sub-populations within PAD which require treatment.
  • Gain an understanding of the specific markets that have the largest number of PAD patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, IN, TR, CA, AU, NL, AR, KR, MX, GR, SA

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis &Clinical Course

Key Co-morbid Conditions /Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Peripheral Arterial Disease

Features of PAD

  • Severity and Symptoms of PAD
  • Profile of Symptoms in Symptomatic PAD Patients
  • Cholesterol Levels in PAD Patients
  • Conditions Associated with PAD

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • Fontaine Classification System for PAD
  • Rutherford Classification System for PAD
  • Society for Vascular Surgery WIfI for PAD classification
  • Society for Vascular Surgery TASC II Classification for PAD
  • Prevalence of PAD, total (000s)
  • Prevalence of PAD, males (000s)
  • Prevalence of PAD, females (000s)
  • PAD patients by severity, total (000s)
  • PAD patients by symptom status, total (000s)
  • Small-vessel or large-vessel involvement in PAD patients, total (000s)
  • Profile of IC type in Symptomatic PAD patients, total (000s)
  • Grade of symptoms in symptomatic PAD patients, total (000s)
  • 1-year outcome of patients with acute limb ischemia, total (000s)
  • Total cholesterol in PAD patients, total (000s)
  • Prevalence of hypertension in PAD patients, total (000s)
  • Prevalence of diabetes in PAD patients, total (000s)
  • Prevalence of CHF in PAD patients, total (000s)
  • Prevalence of CAD in PAD patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of PAD by 5-yr age cohort, males (000s)
  • USA Prevalence of PAD by 5-yr age cohort, females (000s)
  • France Prevalence of PAD by 5-yr age cohort, males (000s)
  • France Prevalence of PAD by 5-yr age cohort, females (000s)
  • Germany Prevalence of PAD by 5-yr age cohort, males (000s)
  • Germany Prevalence of PAD by 5-yr age cohort, females (000s)
  • Italy Prevalence of PAD by 5-yr age cohort, males (000s)
  • Italy Prevalence of PAD by 5-yr age cohort, females (000s)
  • Spain Prevalence of PAD by 5-yr age cohort, males (000s)
  • Spain Prevalence of PAD by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of PAD by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of PAD by 5-yr age cohort, females (000s)
  • Brazil Prevalence of PAD by 5-yr age cohort, males (000s)
  • Brazil Prevalence of PAD by 5-yr age cohort, females (000s)
  • Japan Prevalence of PAD by 5-yr age cohort, males (000s)
  • Japan Prevalence of PAD by 5-yr age cohort, females (000s)
  • India Prevalence of PAD by 5-yr age cohort, males (000s)
  • India Prevalence of PAD by 5-yr age cohort, females (000s)
  • Mexico Prevalence of PAD by 5-yr age cohort, males (000s)
  • Mexico Prevalence of PAD by 5-yr age cohort, females (000s)
  • Turkey Prevalence of PAD by 5-yr age cohort, males (000s)
  • Turkey Prevalence of PAD by 5-yr age cohort, females (000s)
  • Sweden Prevalence of PAD by 5-yr age cohort, males (000s)
  • Sweden Prevalence of PAD by 5-yr age cohort, females (000s)
  • Canada Prevalence of PAD by 5-yr age cohort, males (000s)
  • Canada Prevalence of PAD by 5-yr age cohort, females (000s)
  • Australia Prevalence of PAD by 5-yr age cohort, males (000s)
  • Australia Prevalence of PAD by 5-yr age cohort, females (000s)
  • Greece Prevalence of PAD by 5-yr age cohort, males (000s)
  • Greece Prevalence of PAD by 5-yr age cohort, females (000s)
  • Saudi Arabia Prevalence of PAD by 5-yr age cohort, males (000s)
  • Saudi Arabia Prevalence of PAD by 5-yr age cohort, females (000s)
  • South Korea Prevalence of PAD by 5-yr age cohort, males (000s)
  • South Korea Prevalence of PAD by 5-yr age cohort, females (000s)
  • The Netherlands Prevalence of PAD by 5-yr age cohort, males (000s)
  • The Netherlands Prevalence of PAD by 5-yr age cohort, females (000s)
  • Argentina Prevalence of PAD by 5-yr age cohort, males (000s)
  • Argentina Prevalence of PAD by 5-yr age cohort, females (000s)
  • China Prevalence of PAD by 5-yr age cohort, males (000s)
  • China Prevalence of PAD by 5-yr age cohort, females (000s)
Back to Top